B. Sharda Pharma Pellets Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
- Revenue Growth 452.43%
- Profit Growth 318.90%
- Ebitda 2.68%
- Net Worth 186.48%
- Total Assets 57.01%
About B. Sharda Pharma Pellets
B. Sharda Pharma Pellets Private Limited (BSPPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2020 (Four years and ten months 9 days old ). Its registered office is in Banaskantha, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.00 Cr.
Saurav Kela and Priyank Kela serve as directors at the Company.
Company Details
-
Location
Banaskantha, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2020PTC113344
-
Company No.
113344
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Mar 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at B. Sharda Pharma Pellets?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurav Kela
|
Director | 31-Mar-2020 | Current |
|
Priyank Kela
|
Director | 31-Mar-2020 | Current |
Financial Performance of B. Sharda Pharma Pellets.
B. Sharda Pharma Pellets Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 452.43% increase. The company also saw a substantial improvement in profitability, with a 318.9% increase in profit. The company's net worth Soared by an impressive increase of 186.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B. Sharda Pharma Pellets?
Unlock access to B. Sharda Pharma Pellets's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
B. Sharda Pharma-Chem LimitedPriyank Kela is a mutual person
Charges (Loans)
₹40.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2021 | Hdfc Bank Limited | ₹4.00 Cr | Open |
How Many Employees Work at B. Sharda Pharma Pellets?
B. Sharda Pharma Pellets has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B. Sharda Pharma Pellets, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B. Sharda Pharma Pellets's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.